MedTrace Logo

Abnormal Fecal Microbiota in Healthy Subjects at High Risk for Crohn's Disease

NCT02826330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2019-10-11

No results posted yet for this study

Summary

Transversal multicentric French study on the microbiota in patients with Crohn's disease and their first degree healthy relatives The primary objective is the comparison of microbiota between patients with CD, healthy controls non genetically linked and first degree healthy relatives of patients with CD.

Conditions

Interventions

OTHER

biomarkers

fecal microbiota analysis antibodies in serum and saliva DNA polymorphisms

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Corinne Gower-Rousseau, MD, PhD · University Hospital, Lille

Eligibility

Min Age
8 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-03
Primary Completion
2019-04-03
Completion
2019-04-03

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02826330 on ClinicalTrials.gov